Research progress of perivascular adipose tissue inflammation involved in the occurrence and development of aortic dissection

doi:10.3760/cma.j.issn.1007-1245.2024.10.002

Abstract

Abstract:

Aortic dissection (AD), also referred to as aortic dissection aneurysm, is a perilous condition associated with high mortality rate. Recent studies investigating the alterations in inflammatory markers during the disease progression suggest that inflammation plays a crucial role in determining the clinical outcomes of AD. The initial manifestation of inflammatory response occurs within the aortic adventitia and surrounding adipose tissue. Perivascular adipose tissue (PVAT) orchestrates arterial wall inflammation through proinflammatory mechanisms, which are closely linked to the occurrence and progression of various cardiovascular diseases. Consequently, detecting and intervening in PVAT inflammation holds immense significance for comprehending early pathophysiological changes in AD and implementing timely preventive measures among individuals at high risk.

Key words:

Aortic dissection, Perivascular adipose tissue, Inflammation, Review

摘要：

主动脉夹层（AD）又称主动脉夹层动脉瘤，其起病凶险、病死率高。近年来，对其疾病进程中炎症指标变化的研究提示炎症与疾病临床转归的关系密切，且炎症反应最早出现在主动脉外膜及周围脂肪组织中。血管周围脂肪组织（PVAT）通过促炎机制介导动脉管壁炎症，与多种心血管疾病的发生发展密切相关。因此，针对PVAT炎症的检测及干预对研究AD早期病理生理变化以及AD高危人群早期预防具有重要意义。

关键词:

主动脉夹层, 血管周围脂肪组织, 炎症, 综述

Wang Ao, Zou Mingrui, Han Yuexin, Wang Yujiu.

Research progress of perivascular adipose tissue inflammation involved in the occurrence and development of aortic dissection [J]. International Medicine and Health Guidance News, 2024, 30(10): 1590-1593.

王傲邹明锐韩曰信王玉玖.

血管周围脂肪组织炎症反应参与主动脉夹层发生发展的研究进展 [J]. 国际医药卫生导报, 2024, 30(10): 1590-1593.

References

[1] Hagan PG, Nienaber CA, Isselbacher EM, et al. The international registry of acute aortic dissection (IRAD): new insights into an old disease[J]. JAMA, 2000, 283(7):897-903. DOI: 10.1001/jama.283.7.897.
[2] Ren W, Wang Z, Wang J, et al. IL-5 overexpression attenuates aortic dissection by reducing inflammation and smooth muscle cell apoptosis[J]. Life Sci, 2020, 241:117144. DOI: 10.1016/j.lfs.2019.117144.
[3] Xu H, Du S, Fang B, et al. VSMC-specific EP4 deletion exacerbates angiotensin II-induced aortic dissection by increasing vascular inflammation and blood pressure[J]. Proc Natl Acad Sci U S A, 2019, 116(17):8457-8462. DOI: 10.1073/pnas.1902119116.
[4] Lu HY, Hsu HL, Li CH, et al. Hydrogen sulfide attenuates aortic remodeling in aortic dissection associating with moderated inflammation and oxidative stress through a NO-dependent pathway[J]. Antioxidants (Basel), 2021, 10(5):682. DOI: 10.3390/antiox10050682.
[5] Chumachenko PV, Postnov AY, Ivanova AG, et al. Thoracic aortic aneurysm and factors affecting aortic dissection[J]. J Pers Med, 2020, 10(4):153. DOI: 10.3390/jpm10040153.
[6] Hillock-Watling C, Gotlieb AI. The pathobiology of perivascular adipose tissue (PVAT), the fourth layer of the blood vessel wall[J]. Cardiovasc Pathol, 2022, 61:107459. DOI: 10.1016/j.carpath.2022.107459.
[7] Chen Y, Qin Z, Wang Y, et al. Role of inflammation in vascular disease-related perivascular adipose tissue dysfunction[J]. Front Endocrinol (Lausanne), 2021, 12:710842. DOI: 10.3389/fendo.2021.710842.
[8] 冯小航,樊天斐,侯杨峰,等.炎性细胞和主动脉固有细胞在主动脉夹层中的研究现状[J].中华心血管病杂志,2023,51(1):92-98. DOI:10.3760/cma.j.cn112148-20221206- 00966.
[9] Zhang J, Tecson KM, McCullough PA. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy[J]. Rev Cardiovasc Med, 2020, 21(3):315-319. DOI: 10.31083/j.rcm.2020.03.126.
[10] Majolée J, Kovačević I, Hordijk PL. Ubiquitin-based modifications in endothelial cell-cell contact and inflammation[J]. J Cell Sci, 2019, 132(17):jcs227728. DOI: 10.1242/jcs.227728.
[11] Wang T, He X, Liu X, et al. Weighted gene co-expression network analysis identifies FKBP11 as a key regulator in acute aortic dissection through a NF-kB dependent pathway[J]. Front Physiol, 2017, 8:1010. DOI: 10.3389/fphys.2017.01010.
[12] Tang N, Sun B, Gupta A, et al. Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-κB in endothelial cells[J]. FASEB J, 2016, 30(9):3097-3106. DOI: 10.1096/fj.201600368RR.
[13] Shen YH, LeMaire SA, Webb NR, et al. Aortic aneurysms and dissections series[J]. Arterioscler Thromb Vasc Biol, 2020, 40(3):e37-e46. DOI: 10.1161/ATVBAHA.120. 313991.
[14] Wu D, Ren P, Zheng Y, et al. NLRP3 (nucleotide oligomerization domain-like receptor family, pyrin domain containing 3)-caspase-1 inflammasome degrades contractile proteins: implications for aortic biomechanical dysfunction and aneurysm and dissection formation[J]. Arterioscler Thromb Vasc Biol, 2017, 37(4):694-706. DOI: 10.1161/ATVBAHA.116.307648.
[15] Milewicz DM, Guo DC, Tran-Fadulu V, et al. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction[J]. Annu Rev Genomics Hum Genet, 2008, 9:283-302. DOI: 10.1146/annurev.genom.8.080706.092303.
[16] Zeng T, Gan J, Liu Y, et al. ADAMTS-5 decreases in aortas and plasma from aortic dissection patients and alleviates angiotensin II-induced smooth muscle-cell apoptosis[J]. Front Cardiovasc Med, 2020, 7:136. DOI: 10.3389/fcvm.2020.00136.
[17] Chen Y, Zhang T, Yao F, et al. Dysregulation of interaction between LOXhigh fibroblast and smooth muscle cells contributes to the pathogenesis of aortic dissection[J]. Theranostics, 2022, 12(2):910-928. DOI: 10.7150/thno.66059.
[18] Aoki H, Majima R, Hashimoto Y, et al. Ying and Yang of Stat3 in pathogenesis of aortic dissection[J]. J Cardiol, 2021, 77(5):471-474. DOI: 10.1016/j.jjcc.2020.10.010.
[19] Zhou H, Ren Y, Xiao J, et al. Changes in aortic collagen in β-aminopropionitrile-induced acute aortic dissection[J]. Ann Transl Med, 2021, 9(20):1574. DOI: 10.21037/atm-21-4933.
[20] Tieu BC, Lee C, Sun H, et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice[J]. J Clin Invest, 2009, 119(12):3637-3651. DOI: 10.1172/JCI38308.
[21] Li X, Ma Z, Zhu YZ. Regional heterogeneity of perivascular adipose tissue: morphology, origin, and secretome[J]. Front Pharmacol, 2021, 12:697720. DOI: 10.3389/fphar.2021.697720.
[22] Ye M, Ruan CC, Fu M, et al. Developmental and functional characteristics of the thoracic aorta perivascular adipocyte[J]. Cell Mol Life Sci, 2019, 76(4):777-789. DOI: 10.1007/s00018-018-2970-1.
[23] Hildebrand S, Stümer J, Pfeifer A. PVAT and its relation to brown, beige, and white adipose tissue in development and function[J]. Front Physiol, 2018, 9:70. DOI: 10.3389/fphys.2018.00070.
[24] Wolf D, Ley K. Immunity and inflammation in atherosclerosis[J]. Circ Res, 2019, 124(2):315-327. DOI: 10.1161/CIRCRESAHA.118.313591.
[25] Chang L, Villacorta L, Li R, et al. Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-γ deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis[J]. Circulation, 2012, 126(9):1067-1078. DOI: 10.1161/CIRCULATIONAHA.112.104489.
[26] Xiong W, Zhao X, Villacorta L, et al. Brown adipocyte-specific PPARγ (peroxisome proliferator-activated receptor γ) deletion impairs perivascular adipose tissue development and enhances atherosclerosis in mice[J]. Arterioscler Thromb Vasc Biol, 2018, 38(8):1738-1747. DOI: 10.1161/ATVBAHA.118. 311367.
[27] Vernochet C, Peres SB, Davis KE, et al. C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists[J]. Mol Cell Biol, 2009, 29(17):4714-4728. DOI: 10.1128/MCB.01899-08.
[28] Adachi Y, Ueda K, Nomura S, et al. Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling[J]. Nat Commun, 2022, 13(1):5117. DOI: 10.1038/s41467-022-32658-6.
[29] Wang Z, Lu H, Garcia-Barrio M, et al. RNA sequencing reveals perivascular adipose tissue plasticity in response to angiotensin II[J]. Pharmacol Res, 2022, 178:106183. DOI: 10.1016/j.phrs.2022.106183.
[30] Gruzdeva OV, Dyleva YA, Belik EV, et al. Relationship between epicardial and coronary adipose tissue and the expression of adiponectin, leptin, and interleukin 6 in patients with coronary artery disease[J]. J Pers Med, 2022, 12(2):129. DOI: 10.3390/jpm12020129.
[31] Mazzotta C, Basu S, Gower AC, et al. Perivascular adipose tissue inflammation in ischemic heart disease[J]. Arterioscler Thromb Vasc Biol, 2021, 41(3):1239-1250. DOI: 10.1161/ATVBAHA.120.315865.
[32] Lohmann C, Schäfer N, von Lukowicz T, et al. Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets[J]. Atherosclerosis, 2009, 207(2):360-367. DOI: 10.1016/j.atherosclerosis.2009.05.004.
[33] Kaur S, Bansal Y, Kumar R, et al. A panoramic review of IL-6: structure, pathophysiological roles and inhibitors[J]. Bioorg Med Chem, 2020, 28(5):115327. DOI: 10.1016/j.bmc.2020.115327.
[34] Kang S, Kishimoto T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms[J]. Exp Mol Med, 2021, 53(7):1116-1123. DOI: 10.1038/s12276-021-00649-0.
[35] Nosalski R, Guzik TJ. Perivascular adipose tissue inflammation in vascular disease[J]. Br J Pharmacol, 2017, 174(20):3496-3513. DOI: 10.1111/bph.13705.
[36] Wen G, An W, Chen J, et al. Genetic and pharmacologic inhibition of the neutrophil elastase inhibits experimental atherosclerosis[J]. J Am Heart Assoc, 2018, 7(4):e008187. DOI: 10.1161/JAHA.117.008187.
[37] Ansaldo AM, Montecucco F, Sahebkar A, et al. Epicardial adipose tissue and cardiovascular diseases[J]. Int J Cardiol, 2019, 278:254-260. DOI: 10.1016/j.ijcard.2018. 09.089.
[38] Antonopoulos AS, Sanna F, Sabharwal N, et al. Detecting human coronary inflammation by imaging perivascular fat[J]. Sci Transl Med, 2017, 9(398):eaal2658. DOI: 10.1126/scitranslmed.aal2658.
[39] Virdis A, Colucci R, Bernardini N, et al. Microvascular endothelial dysfunction in human obesity: role of TNF-α[J]. J Clin Endocrinol Metab, 2019, 104(2):341-348. DOI: 10.1210/jc.2018-00512.
[40] Liu Y, Sun Y, Hu C, et al. Perivascular adipose tissue as an indication, contributor to, and therapeutic target for atherosclerosis[J]. Front Physiol, 2020, 11:615503. DOI: 10.3389/fphys.2020.615503.
[41] Liu M, Song Y, Han Z. Study on the effect of LncRNA AK094457 on OX-LDL induced vascular smooth muscle cells[J]. Am J Transl Res, 2019, 11(9):5623-5633.
[42] Miao CY, Li ZY. The role of perivascular adipose tissue in vascular smooth muscle cell growth[J]. Br J Pharmacol, 2012, 165(3):643-658. DOI: 10.1111/j.1476-5381.2011. 01404.x.
[43] Horimatsu T, Kim HW, Weintraub NL. The role of perivascular adipose tissue in non-atherosclerotic vascular disease[J]. Front Physiol, 2017, 8:969. DOI: 10.3389/fphys.2017.00969.
[44] Abyaneh HS, Regenold M, McKee TD, et al. Towards extracellular matrix normalization for improved treatment of solid tumors[J]. Theranostics, 2020, 10(4):1960-1980. DOI: 10.7150/thno.39995.
[45] Xiao Z, Kong B, Yang H, et al. Key player in cardiac hypertrophy, emphasizing the role of toll-like receptor 4[J]. Front Cardiovasc Med, 2020, 7:579036. DOI: 10.3389/fcvm.2020.579036.